aid: iantrek
name: Iantrek
description: 'Iantrek, Inc. is a venture-backed ophthalmic medical technology company
  headquartered in White Plains, New York, pioneering the field it calls bio-interventional
  ophthalmic surgery (BIOS) for the treatment of glaucoma. Founded in 2019 by ophthalmic
  innovator Sean Ianchulev, MD, MPH, the company develops micro-interventional surgical
  devices that reinforce and restore the eye''s natural aqueous outflow pathways with
  biologic allograft tissue rather than bypassing or removing tissue. Its commercial
  and pipeline portfolio includes AlloFlo Uveo, AlloSert Uveo, C-Rex and AlloSpan Canal.
  Iantrek has raised approximately $103M across its rounds, including a $42M Series C
  used to launch AlloFlo Uveo in the United States in October 2025. Iantrek publishes
  a corporate and surgeon-facing marketing website at iantrekmed.com; it operates no
  public developer portal, documentation, or machine-readable API surface.'
image: https://cdn.prod.website-files.com/68a8587a72d95eb3c8e82014/68af21a8c819016c8870130b_Graph%20Card.png
url: https://raw.githubusercontent.com/api-evangelist/iantrek/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profile
x-tier-reason: enriched-no-api-surface
specificationVersion: '0.23'
created: '2026-08-04'
modified: '2026-08-04'
tags:
- Company
- Medical Devices
- Health Care
- Ophthalmology
- Glaucoma
- Surgery
- Medical Technology
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://iantrekmed.com/
- type: About
  url: https://iantrekmed.com/about
- type: Products
  name: AlloFlo Uveo
  url: https://iantrekmed.com/alloflo
- type: Products
  name: AlloSert Uveo
  url: https://iantrekmed.com/allosert
- type: Products
  name: C-Rex
  url: https://iantrekmed.com/crex
- type: Testimonials
  url: https://iantrekmed.com/testimonials
- type: Videos
  name: Surgical Videos
  url: https://iantrekmed.com/surgical-videos
- type: News
  url: https://iantrekmed.com/news
- type: Contact
  url: https://iantrekmed.com/contact
- type: Support
  url: https://iantrekmed.com/contact-v1
- type: Careers
  url: https://iantrekmed.com/careers
- type: LinkedIn
  url: https://www.linkedin.com/company/iantrek-inc/
- type: GitHubOrganization
  url: https://github.com/iantrek
- type: PrivacyPolicy
  url: https://iantrekmed.com/privacy-policy
- type: TermsOfService
  url: https://iantrekmed.com/terms-of-service
- type: DomainSecurity
  url: security/iantrek-domain-security.yml
- type: LLMsTxt
  url: llms/iantrek-llms.txt
x-enrichment:
  date: '2026-08-04'
  status: nochange
  artifacts_added: 0
  pass: local-v1
  note: 'Second pass — independently re-verified, no API surface found and no new
    artifact was produced. Contract discovery re-probed iantrekmed.com and
    www.iantrekmed.com for /openapi.json, /openapi.yaml, /swagger.json,
    /v1/openapi.json, /api-docs, /docs, /redoc, /api, /graphql, /llms.txt,
    /sitemap.xml and every /.well-known/ path including both A2A agent-card paths
    (/.well-known/agent-card.json and the legacy /.well-known/agent.json): all 36
    probes returned HTTP 404. api./developer./docs./portal./status./trust./app./dev./mcp./agent./data./cdn.
    subdomains are all NXDOMAIN. iantrek.com is not first-party (unrelated parked
    host returning a service-provider error page). Zero packages on npm, PyPI,
    RubyGems, crates.io, NuGet and Packagist. The first-party GitHub org
    github.com/iantrek (created 2024-04-24) holds one repository, .github, carrying
    only a profile README. probe-security-programs.py returned vdp=none trust=none,
    so no vulnerability-disclosure or trust-center artifact was written. The site is
    a 16-page Webflow marketing and surgeon-facing site. Iantrek is a medical-device
    manufacturer; no agent card, MCP server, or specification was authored on its
    behalf. This pass added only real published product/content pointers (AlloSert
    Uveo, C-Rex, Testimonials, Surgical Videos) to common[].'